The increasing prevalence of liver disorders, growing awareness of hepatic encephalopathy management, and rising demand for amino acid-based therapeutics are driving the growth of the ornithine aspartate market. However, the market also faces several challenges. High treatment costs, stringent regulatory approval processes, and limited awareness in developing regions can restrict...